Blockade of neuropsin, a serine protease, ameliorates kindling epilepsy |
| |
Authors: | Yoshiharu Momota Shigetaka Yoshida Jiro Ito Masao Shibata Keiko Kato Katsutoshi Sakurai Kazumasa Matsumoto Sadao Shiosaka |
| |
Affiliation: | Division of Structural Cell Biology, Nara Institute of Science and Technology, 8916–5 Takayama, Ikoma, Nara, 630–01 Japan,;JBC Inc., Fukue, Kaizu, Gifu, 503‐06, Japan,;Medical and Biological Laboratories Co. Ltd., Fukue, Kaizu, Gifu, 503‐06, Japan |
| |
Abstract: | The behavioural and electrographical abnormalities associated with seizures in epileptic (kindled) mice correspond with those of human epilepsy. In kindled mice, neuropsin was markedly increased in the hippocampus and cerebral cortices. A single intraventricular injection of monoclonal antibodies specific to neuropsin reduced or eliminated the epileptic pattern noted on electroencephalograms and, as a result markedly inhibited the progression of kindling. Therefore, neuropsin appears to be a key protein controlling pathogenic events in the hippocampus, and thus neuropsin inhibitors might be useful for treatment of epilepsy. |
| |
Keywords: | hippocampus kindling neuropsin serine protease |
|
|